Incazelo enemininingwane
I-Hepatitis E ibangelwa igciwane le-hepatitis (HEV) elakhiwe.I-HEV iyi-enterovirus enezimpawu zomtholampilo kanye ne-epidemiology efana ne-hepatitis A.
I-Anti-HEIgM itholwa ku-serum phakathi nesigaba esibucayi se-viral hepatitis E futhi ingasetshenziswa njengenkomba yokuxilonga kusenesikhathi.I-anti-HEIgM ye-titer ephansi nayo ingalinganiswa ngesikhathi sokululama.
I-Hepatitis E yisifo esithathelwanayo esiyingozi esisakazwa ngomlomo wendle.Kusukela kwagqashuka isifo sokusha kwesibindi kohlobo E eNdiya ngo-1955 ngenxa yokungcoliswa kwamanzi, besilokhu sikhona e-India, Nepal, Sudan, Kyrgyzstan of the Soviet Union naseXinjiang eChina.
Ngo-September 1989, iNgqungquthela Yamazwe Ngamazwe YaseTokyo Ye-HNANB Nezifo Ezithathelwanayo Ngegazi yaqanjwa ngokusemthethweni i-hepatitis E, kanye ne-ejenti yayo eyimbangela, i-Hepatitis E Virus (HEV), iyingxenye ye-taxonomically yohlobo lwegciwane le-Hepatitis E emndenini wegciwane le-Hepatitis E.
(1) Ukutholwa kwe-serum anti-HEV IgM kanye ne-anti-HEV IgG: Kusetshenziswa ukutholwa kwe-EIA.I-Serum anti-HEV IgG yaqala ukutholakala ezinsukwini ezingu-7 ngemva kokuqala, okungenye yezimpawu zokutheleleka nge-HEV;
(2) Ukutholwa kwe-HEV RNA ku-serum nendle: Ngokuvamile amasampula aqoqwe ekuqaleni kwesigaba sokuqala aqoqwa kusetshenziswa ukusesha kwenethiwekhi yemfundo yesayensi yesayensi ye-RT-PCR.